One Global Service Provider Limited engages in the provision of healthcare services worldwide. The company offers diagnostic services, including anemia, antenatal, diabetes, diabetes monitoring, hypertension, kidney, and lipid profiles, as well as liver function tests; and healthcare services, such as end-to-end solutions in industrial occupational check-ups, population screening for non-communicable diseases, disease surveillance programs, electronic medical records and health registry, health analytics for predictive and preventive actions, and wellness programs for lifestyle diseases. It also provides laboratory services, such as biochemistry, microbiology, hematology and coagulation, histopathology and cytopathology, clinical pathology, molecular diagnostics, and serology. In addition, the company offers healthcare products, such as medical devices, equipment, medical consumables, and reagents through an online platform; and healthcare solutions comprising home-based health screeni
| Current Price | ₹490.90 |
|---|---|
| Market Cap | ₹959 Cr |
| Sector | Consumer Discretionary > Consumer Discretionary Distribution and Retail > Specialty Retail |
| Sub-Industry | Health Care Services > Healthcare Provider Support Persons |
| P/E Ratio | 13.8 |
| Return on Equity | 65.28% |
| 52-Week Range | ₹221.40 – ₹790.00 |
| Beta (1Y) | -0.35 |
| Dividend Yield | 0.20% |
One Global Service Provider Ltd is trading at ₹490.90, with a market capitalisation of ₹959 Cr.
One Global Service Provider Ltd operates in the Consumer Discretionary > Consumer Discretionary Distribution and Retail > Specialty Retail space (Health Care Services > Healthcare Provider Support Persons).
One Global Service Provider Ltd has a P/E of 13.8 and a return on equity of 65.28%.